Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Identification of novel splicing variants of protein tyrosine phosphatase receptor type Z.

Fujikawa A, Chow JPH, Matsumoto M, Suzuki R, Kuboyama K, Yamamoto N, Noda M.

J Biochem. 2017 Nov 1;162(5):381-390. doi: 10.1093/jb/mvx042.

PMID:
28992190
2.

Immunomodulatory effects of adipose tissue-derived stem cells on elastin scaffold remodeling in diabetes.

Chow JP, Simionescu DT, Carter AL, Simionescu A.

Tissue Eng Regen Med. 2016 Dec 17;13(6):701-712. doi: 10.1007/s13770-016-0018-x. eCollection 2016 Dec.

3.

Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells.

Mak JP, Man WY, Chow JP, Ma HT, Poon RY.

Oncotarget. 2015 Aug 28;6(25):21074-84.

4.

Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.

Li J, Hong MJ, Chow JP, Man WY, Mak JP, Ma HT, Poon RY.

Oncotarget. 2015 Apr 20;6(11):9327-40.

5.

Misalignment tolerable coil structure for biomedical applications with wireless power transfer.

Chow JP, Chen N, Chung HS, Chan LL.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:775-8. doi: 10.1109/EMBC.2013.6609615.

PMID:
24109802
6.

PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy.

Chow JP, Man WY, Mao M, Chen H, Cheung F, Nicholls J, Tsao SW, Li Lung M, Poon RY.

Mol Cancer Ther. 2013 Nov;12(11):2517-28. doi: 10.1158/1535-7163.MCT-13-0010. Epub 2013 Aug 26.

7.

The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery.

Chow JP, Poon RY.

Oncogene. 2013 Oct;32(40):4778-88. doi: 10.1038/onc.2012.504. Epub 2012 Nov 12.

PMID:
23146904
8.

Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol.

Chow JP, Simionescu DT, Warner H, Wang B, Patnaik SS, Liao J, Simionescu A.

Biomaterials. 2013 Jan;34(3):685-95. doi: 10.1016/j.biomaterials.2012.09.081. Epub 2012 Oct 24.

9.

Inhibition of Eg5 acts synergistically with checkpoint abrogation in promoting mitotic catastrophe.

Chen Y, Chow JP, Poon RY.

Mol Cancer Res. 2012 May;10(5):626-35. doi: 10.1158/1541-7786.MCR-11-0491. Epub 2012 Apr 20.

10.

Consensus substrate sequence for protein-tyrosine phosphatase receptor type Z.

Fujikawa A, Fukada M, Makioka Y, Suzuki R, Chow JP, Matsumoto M, Noda M.

J Biol Chem. 2011 Oct 28;286(43):37137-46. doi: 10.1074/jbc.M111.270140. Epub 2011 Sep 2.

11.

Determinants of mitotic catastrophe on abrogation of the G2 DNA damage checkpoint by UCN-01.

On KF, Chen Y, Ma HT, Chow JP, Poon RY.

Mol Cancer Ther. 2011 May;10(5):784-94. doi: 10.1158/1535-7163.MCT-10-0809. Epub 2011 Mar 23.

12.

Inhibitory phosphorylation of cyclin-dependent kinase 1 as a compensatory mechanism for mitosis exit.

Chow JP, Poon RY, Ma HT.

Mol Cell Biol. 2011 Apr;31(7):1478-91. doi: 10.1128/MCB.00891-10. Epub 2011 Jan 24.

13.

Metalloproteinase- and gamma-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z.

Chow JP, Fujikawa A, Shimizu H, Suzuki R, Noda M.

J Biol Chem. 2008 Nov 7;283(45):30879-89. doi: 10.1074/jbc.M802976200. Epub 2008 Aug 18.

14.

Plasmin-mediated processing of protein tyrosine phosphatase receptor type Z in the mouse brain.

Chow JP, Fujikawa A, Shimizu H, Noda M.

Neurosci Lett. 2008 Sep 19;442(3):208-12. doi: 10.1016/j.neulet.2008.07.028. Epub 2008 Jul 16.

PMID:
18647637
15.

Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma.

Cheung ST, Fan ST, Lee YT, Chow JP, Ng IO, Fong DY, Lo CM.

Transplantation. 2008 Jan 15;85(1):81-7. doi: 10.1097/01.tp.0000298003.88530.11.

PMID:
18192916
16.

Tyrosine phosphorylation of ErbB4 is enhanced by PSD95 and repressed by protein tyrosine phosphatase receptor type Z.

Fujikawa A, Chow JP, Shimizu H, Fukada M, Suzuki R, Noda M.

J Biochem. 2007 Sep;142(3):343-50. Epub 2007 Jul 23.

PMID:
17646177
17.
18.

Protein tyrosine phosphatase receptor type Z is inactivated by ligand-induced oligomerization.

Fukada M, Fujikawa A, Chow JP, Ikematsu S, Sakuma S, Noda M.

FEBS Lett. 2006 Jul 24;580(17):4051-6. Epub 2006 Jun 27.

19.

The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpoint.

Ho CC, Siu WY, Chow JP, Lau A, Arooz T, Tong HY, Ng IO, Poon RY.

Exp Cell Res. 2005 Mar 10;304(1):1-15. Epub 2004 Nov 21.

PMID:
15707569
20.
21.

DNA damage during the spindle-assembly checkpoint degrades CDC25A, inhibits cyclin-CDC2 complexes, and reverses cells to interphase.

Chow JP, Siu WY, Fung TK, Chan WM, Lau A, Arooz T, Ng CP, Yamashita K, Poon RY.

Mol Biol Cell. 2003 Oct;14(10):3989-4002. Epub 2003 Jul 25.

22.

Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints.

Chow JP, Siu WY, Ho HT, Ma KH, Ho CC, Poon RY.

J Biol Chem. 2003 Oct 17;278(42):40815-28. Epub 2003 Aug 11.

23.

Periodontal and cardiovascular diseases.

Chow JP.

J Am Dent Assoc. 1998 Apr;129(4):410. No abstract available.

PMID:
9573691

Supplemental Content

Support Center